• ¼Ò¾Æ ¹æ±¤¿¡ ¹ß»ýÇÑ È¾¹®±ÙÀ°Á¾ 1¿¹

• A Case of Bladder Rhabdomyosarcoma in a Child

• Á¤ÈñÁ¾

• ÀÌ»ï·ã/¹Ú±¤¼º/·ù¼ö¹æ/±¹ÈÆ/ȲÅÂÁÖ

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  604 ~ 610

• ¸¸¼º È£Áß±¸¼º ¹éÇ÷º´ 1¿¹

• A Case of Chronic Neutrophilic Leukemia

• Á¶ºÀ±â

• ±Ç¹üÂù/ÀÌÇѱÕ/³²±ÙÇÏ/±è¼®ÁØ/ÀÌÁß±â/Á¤¼¼À±

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  597 ~ 603

• µ¿Àû½Ã½ºÅÛÀÇ °è¼öº¯È­ °ËÃâ¿¡ ÀÇÇÑ ¾ÏÀÇ Á¶±âÁø´Ü¿¡ °üÇÑ ¿¬±¸

• An Early Diagnosis of Cancer by the Detection of Parameter Changes in Dynamical Systems

• À̱Ǽø

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  589 ~ 596

• °í¿ë·®ÀÇ Cisplatin º´ÇÕÈ­Çпä¹ý½Ã ±Þ¼º ÁøÅäÈ¿°ú¿¡ ´ëÇÑ Granisetron°ú Metoclopramide, Dexamethasone, ...

• A Comparison of the Acute Antiemetic Effect of Granisetron with Combination of Metoclopramide, Dexam...

• ½Å¿ø¿ë

• ¹Ú¼º±Ô/ÀüÁø¿ì/¿øÁ¾È£/¹é½ÂÈ£/¿Àµµ¿¬/È«´ë½Ä/¹ÚÈñ¼÷

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  582 ~ 588

• Á¤¸Æ ÁÖ»ç¿ë ±×¶ó´Ï¼¼Æ®·Ð 1ÀÏ ¶Ç´Â 2ÀÏ Åõ¿©°¡ CisplatinÀ» Æ÷ÇÔÇÑ Ç׾Ͽä¹ý½Ã ¿À½É±¸ÅäÀÇ ¿¹¹æ°ú Quality...

• Effect of One-day(G1) and Two-day(G2) Schedule of Intravenous Granisetron on Prevention of Nausea an...

• ¹Î¿ì¼º

• ¹®ÇѸ²/°­ÁøÇü/ÁøÁ¾·ü/±èÃáÃß/±èµ¿Áý/ÁÖ¼ºÀÚ/°­°æ½É/À¯ÀçºÐ

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  573 ~ 581

• Cisplatinº´¿ë Ç×¾ÏÈ­Çпä¹ý½Ã ¹ß»ýÇÏ´Â ¿À½É ¹× ±¸Åä¿¡ ´ëÇÑ Tropisetron ´ÜÀÏ¿ä¹ý°ú Metoclopramide/Dexa...

• A Prospective Randomized Study Comparing the Efficacy of Tropisetron Versus Metoclopramide, Dexameth...

• ¹Ú±âº¹

• Á¤µ¿ÈÆ/±èÁ¾ÈÆ/±èº´±â/¹Ú»óÀ±/ÀÌÀǵ·/ÀÌ°æÈñ

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  562 ~ 572

• ÀüÀ̼º ½Å¼¼Æ÷¾Ï¿¡¼­ Recombinant Interferon Alpha-2a¸¦ Æ÷ÇÔÇÑ º¸Á¶¿ä¹ýÀÇ È¿°ú

• Effect of Combination Chemotherapy with Recombinant Interferon Alpha-2a for Palliative Therapy of Me...

• ¾ÈÀçõ

• È«±ââ, ·ùÇö¿­

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  555 ~ 561

• Çѱ¹ÀÎ von Hippel-Lindauº´ ȯÀÚ¿¡¼­ Vhl À¯ÀüÀÚÀÇ ¹è¼± µ¹¿¬º¯ÀÌ

• Germline Mutations of VHL gene in Korean von Hippel-Lindau Disease Patients

• ½Å±âÇõ

• ¹Ú±ÔÁÖ/ÀÌ»óÈÆ/ÀÌ»óÀº/Á¤Èñ¿ø/±èÇöÁý/¹ÚÀç°©

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  544 ~ 554

• Çѱ¹Àο¡¼­ÀÇ APC À¯ÀüÀÚ ÀÎÁ¢ CA ¹Úº¹±¸Á¶(D5s346)ÀÇ ´ÙÇü¼º

• CA Repeat Polymorphism at the D5S346 Locus Tightly Linked to Adenomatous Polyposis Coli (APC) Gene i...

• ÇÑÇýÁ¤

• ¿ø¿ëÁø, ¹Ú±ÔÁÖ, ¹Î±âÁÖ

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  533 ~ 543

• »ç¶÷ c-myc ¿ø¾ÏÀ¯ÀüÀÚ¿¡¼­ Benzo(a)pyrene, m-AMSA, Ellipticine ¹× Doxorubicin¿¡ ÀÇÇÑ Topoisomerase II...

• Alterations in DNA Cleavage Site of Topoisomerase II by Benzo(a)pyrene, m-AMSA, Ellipticine and Doxo...

• ³ªÁ¾¼®

• Á¤ÀÎö, ÀÌ⿬

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  520 ~ 532

• Àü¸²¼±¾Ï¿¡ À־ÀÇ ¹æ»ç¼± Ä¡·á: ¿ÜºÎ ¹æ»ç¼± Á¶»ç¿Í I-125ÀÚÀÔ ¹æ»ç¼±Ä¡·á

• Radiation Management for Prostate Cancer: External Beam Irradiation versus Iodine-125 implantation

• Á¶¿ë°©

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  512 ~ 519

• ¿ø¹ß¼º ÀڱðæºÎ¾Ï¿¡¼­ Retinoblastoma À¯ÀüÀÚ ÀÌÇü¼º¼Ò½Ç¿¡ ´ëÇÑ ¿¬±¸

• A Study on the Loss of Heterozygosity of the Retinoblastoma Gene in Primary Uterine Cervical Carcino...

• ÀÌÃá±Ù

• ÃÖ¿µÁÖ/¹ÎÈ«±â/±èÁÖ¿À/Á¶À²Èñ/±èÁø¿ì/±èÀçÈÆ/±èÅÂÀÀ/Á¤Àç±Ù

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  502 ~ 511

• ÆóÁ¾¾çÀÇ Keratin ¾ÆÇüÀÇ ¹ßÇö¿¡ °üÇÑ ¿¬±¸

• Expression of Keratin Subtypes in Lung Tumors

• ±â±ÙÈ«

• ¹ÚÂù±¹, ÃÖöÈñ

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  490 ~ 501

• Æó¾Ï¿¡ ÀÇÇÑ ±â°üÁö Æó¼â¿¡¼­ Nd: YAG ·¹ÀÌÀú Ä¡·á¹ýÀÇ È¿°ú

• The Treatment of Malignant Bronchial Obstruction by Laser Photoablation

• ¹Ú¼º¿µ

• ±èÁø¼­

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  483 ~ 489

• ¹æ»ç¼ºÇÙÁ¾À¸·Î Ç¥ÁöÇÑ ´ÜÀÏŬ·ÐÇ×ü¸¦ ÀÌ¿ëÇÑ »ýÁã ÆóÀüÀ̾ÏÀÇ Ä¡·á

• Radioimmunotherapy for Lung Metastasis of MMTV-induced Breast Cancer in Mice with I-labeled Monoclon...

• ¼Õ»ó±Õ/Tibor Bakacs

• ÀÌÀçÅÂ/ÃÖâ¿î/¾Èº´Ã¶/À̱Ժ¸/M.Belen/Moreno/David Segal ¹éâÈì

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  472 ~ 482

• 9,10-Dimethy1-1, 2-benzanthracene Åõ¿©·Î À¯¹ßµÈ ÈòÁã À¯¹æ¾ÏÁ¾¿¡¼­ Pentosan Polysulfate ¹× AndrogenÀÌ...

• The Effect of Pentosan Polysulfate and Androgen on Angiogenesis in 9,10-Dimethyl-1,2-benzanthracene ...

• ¹®Ã¤°æ

• ±Ç¿ÀÇü, Çã°æ¹ß, ¹é½ÂÇõ

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  461 ~ 471

• À¯¹æ¾Ï ȯÀÚ¿¡¼­ NM23 ´Ü¹é¹ßÇöÀÇ ÀÇÀÇ

• Expression of NM23 Protein in Breast Cancer -An immunohistochemical study-

• À̼öÁ¤

• ¼­ÁØ´ö/±è±â¿µ/½É¹Îö/±Ç±²º¸/±èµ¿¼®

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  451 ~ 460

• À¯¹æ¾Ï ¼¼Æ÷¿¡¼­ Tamoxifen°ú Retinoic Acid°¡ Transforming Growth Factor-B¿¡ ¹ÌÄ¡´Â ¿µÇâ

• Transforming Growth Factor-beta(TGF-B) as a Mediator of Tamoxifen and Retinlic Acid in Breast Cancer

• ¼º³«¼ø

• ÀÌÈñ¿õ, Á¤Ã¶¿î, ±¸ÀÚÀ±

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  443 ~ 450

• ´ëÀå ¹× Á÷Àå¾ÏÁ¾¿¡¼­ÀÇ Proliferating Cell Nuclear Antigen°ú Epidermal Growth Factor ReceptorÀÇ ¹ßÇö...

• Expressionof Proliferating Cell Nuclear Antigen and Epidermal Growth Factor Receptor in Colorectal C...

• ÁÖ¿µÃ¤

• ±èÁعÌ/±è¿µ½Ä/±è¿µ¹è/Ȳż÷

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  432 ~ 442

• ÀÎü À§ ¼±¾Ï Á¶Á÷¿¡¼­ p53 ´Ü¹éÁú ¹ßÇöÀÌ ¿¹ÈÄ¿¡ ¹ÌÄ¡´Â ¿µÇâ

• The Prognostic Significance of the p53 Protein Expression in Gastric Carcinoma

• ÀÌÇÑÀÏ

• Ç㿵¼ö, À¯¿Ï½Ä, ±èÀͼö

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  3È£  427 ~ 431